Top Artificial Organs Companies

The Artificial Organs Market is highly competitive, driven by technological innovation and the growing availability of organ replacements. Key players in the market are working to address the gap between increasing organ failure rates, donor availability and transplant needs. Leading companies such as Abbott Laboratories, Medtronic, Zimmer Biomet, Syncardia Systems, Cochlear Ltd. dominate the market with advanced solutions for heart, kidney, liver and cochlear implants. These companies invest heavily in R&D to improve patient outcomes. For example, through innovations in artificial heart and pancreas solutions, as well as strategic acquisitions of subsidiaries, Medtronic has expanded its product portfolio and market presence. Collaboration between leading companies and research institutes accelerates innovation. Strategic partnerships help companies develop next-generation prosthetic limbs, incorporating cutting-edge technologies such as 3D printing and biocompatible materials to drive performance and longevity high.

Top Player’s Company Profiles

• Braun SE (Germany)

• Boston Scientific Corporation (U.S)

• Getinge AB. (Sweden)

• ABIOMED. (U.S.)

• Asahi Kasei Corporation (Japan)

• Berlin Heart (Germany)

• CARMAT (France)

• Jarvik Heart, Inc. (U.S.)

• Terumo Corporation (Japan)

• SynCardia Systems, LLC (U.S.)

• Nipro Europe Group Companies (Japan)

• Medtronic (Ireland)

• Organovo Holdings Inc. (U.S.)

• NexImmune (U.S.)

• Diabeloop SA (France)

• Admetsys (U.S.)

• Defymed (France)

• Pancreum, Inc. (U.S.)

• Beta Bionics Inc. (U.S.)

• Integra LifeSciences (U.S.)